February 18, 2022
The Society of Nuclear Medicine and Molecular Imaging congratulates Robert Califf, MD, on his confirmation as the 25th Commissioner of the U.S. Food and Drug Administration (FDA).
With decades of experience as a leader in cardiovascular medicine, as well as institutional knowledge of the FDA, there is no doubt that Dr. Califf will prioritize scientific evidence–based policymaking. His work in clinical research and health outcomes research will deeply inform his work with the agency.
We look forward to working closely with Commissioner Califf on our mutual goal of improving human health and patient outcomes and building our partnership to help increase the speed of drug and device innovation.